RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1177%2F1073858420961078

https://w3id.org/ripe/ripe-kg/work/10.1177%2F1073858420961078
SubjectPredicateObject
ripekg:work/10.1177%2F1073858420961078Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury prism:doi 10.1177/1073858420961078
ripekg:work/10.1177%2F1073858420961078Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury dcterms:title Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury
ripekg:work/10.1177%2F1073858420961078Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury rdf:type node1
ripekg:work/10.1177%2F1073858420961078Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1177%2F1073858420961078Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury rdf:type rdfs:Resource
ripekg:work/10.1177%2F1073858420961078Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury rdf:type owl:Thing
ripekg:work/10.1177%2F1073858420961078Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury rdf:type prov:Entity
ripekg:work/10.1177%2F1073858420961078Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury rdf:type ripe:WorkWork
ripekg:work/10.1177%2F1073858420961078Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury owl:sameAs https://semopenalex.org/work/W3094441410
ripekg:work/10.3390%2Fv13060989RETRACTED: Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon http://purl.org/spar/cito/cites ripekg:work/10.1177%2F1073858420961078Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury